Patents by Inventor David K. R. Karaolis

David K. R. Karaolis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8367716
    Abstract: The present invention relates to the use of the cyclic dinucleotide c-di-GMP and cyclic dinucleotide analogues thereof in a method for attenuating virulence of a microbial pathogen or for inhibiting or reducing colonization by a microbial pathogen. This method further inhibits microbial biofilm formation and is capable of treating bacterial infections. The microbial colonization or biofilm formation inhibited or reduced may be on the skin or on nasal or mucosal surface. The microbial colonization or biofilm formation inhibited can also be on the surfaces of medical devices, especially those in close contact with the patient, as well on the surfaces of industrial and construction material where microbial colonization and biofilm formation is of concern.
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: February 5, 2013
    Inventor: David K. R. Karaolis
  • Patent number: 7709458
    Abstract: Cyclic di-GMP or cyclic dinucleotides thereof can be used to inhibit cancer cell proliferation or to increase cancer cell apoptosis in vitro as well as in vivo in a patient.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: May 4, 2010
    Inventors: David K. R. Karaolis, Jean-Pierre Raufman
  • Patent number: 7592326
    Abstract: Cycic di-GMP, or a cyclic dinucleotide analogue thereof that has the same effect as cyclic di-GMP, stimulates or enhances immune or inflammatory response in a patient or enhances the immune response to a vaccine by serving as an adjuvant.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: September 22, 2009
    Inventor: David K. R. Karaolis
  • Patent number: 7569555
    Abstract: Cycic di-GMP, or a cyclic dinucleotide analogue thereof that has the same effect as cyclic di-GMP, stimulates or enhances immune or inflammatory response in a patient or enhances the immune response to a vaccine by serving as an adjuvant. Cyclic di-GMP, or a cyclic dinucleotide analogue thereof, also has neuroprotective properties for use as a neuroprotective agent to inhibit, treat, or ameliorate the effects of injuries, diseases, disorders or conditions that result in neurodegeneration.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: August 4, 2009
    Inventor: David K. R. Karaolis
  • Patent number: 7291465
    Abstract: The present invention relates to a method and diagnostic kit for directly detecting the presence of a specific species of mold/fungi in a sample, particularly a species which is toxic to humans or animals including pets and livestock. The method involves releasing any fungal DNA from the sample and subjecting it to PCR amplification without the need for purifying the DNA.
    Type: Grant
    Filed: February 16, 2005
    Date of Patent: November 6, 2007
    Inventor: David K. R. Karaolis